TOB1 and neoplasm: Six weeks after orthotopic injection, mice carrying TOB1-AS1 overexpressing PANC-1 cells showed exacerbated overall tumor burden (Figure 6D), elevated primary tumor burden, and elevated metastatic burden in the spleen (Figure 6E and Supplementary Figure S13B).